Body burdens of lead in hypertensive nephropathy

Archives of Environmental Health
J D OsterlohB Behrens

Abstract

Chronic lead exposure resulting in blood lead concentrations that exceed 1.93 mumol/l (40 micrograms/dl) or chelatable urinary lead excretion greater than 3.14 mumol (650 micrograms) per 72 h has been associated with renal disease. A previous study had found greater chelatable urine lead excretion in subjects with hypertension and renal failure than in controls with renal failure due to other causes, although mean blood lead concentrations averaged 0.92 mumol/l (19 micrograms/dl). To determine if chelatable urinary lead, blood lead, or the hematologic effect of lead (zinc protoporphyrin) were greater in hypertensive nephropathy (when hypertension precedes elevation of serum creatinine) than in other forms of mild renal failure, we compared 40 study subjects with hypertensive nephropathy to 24 controls having a similar degree of renal dysfunction due to causes other than hypertension. Lead burdens were similar in both the study and control groups as assessed by 72-h chelatable urinary lead excretion after intramuscular injection of calcium disodium EDTA (0.74 +/- 0.63 vs. 0.61 +/- 0.40 mumol per 72 h, respectively), and by blood lead (0.35 +/- 0.23 vs. 0.35 +/- 0.20 mumol/l). We conclude that subjects from a general population w...Continue Reading

References

Jul 3, 1976·Lancet·D G BeeversV M Hawthorne
Sep 1, 1979·International Archives of Occupational and Environmental Health·L AlessioC Zocchetti
Jun 1, 1977·Toxicology and Applied Pharmacology·B J WilliamsM R Hejtmancik
Nov 1, 1979·British Journal of Industrial Medicine·E L BakerJ Throckmorton
Dec 1, 1986·Clinical Pharmacology and Therapeutics·J Osterloh, C E Becker
May 1, 1988·American Journal of Epidemiology·P C ElwoodC Toothill
May 1, 1986·American Journal of Epidemiology·S T WeissF E Speizer
Jan 1, 1987·American Journal of Industrial Medicine·M VerschoorR Zielhuis
Nov 1, 1987·British Journal of Industrial Medicine·D K ParkinsonM M Connell
Jan 1, 1986·Journal of Toxicology and Environmental Health·E J O'FlahertyE Taylor
Mar 1, 1986·Archives of Environmental Health·A GreenbergP J Landrigan
Jan 1, 1986·Upsala Journal of Medical Sciences·K M Reynolds
Jan 1, 1987·American Journal of Industrial Medicine·W L de KortJ J van Hemmen
Jan 25, 1985·JAMA : the Journal of the American Medical Association·W R HarlanL C Harlan
Feb 1, 1985·Scandinavian Journal of Work, Environment & Health·H Kirkby, F Gyntelberg
Nov 1, 1971·Australian and New Zealand Journal of Medicine·B T EmmersonJ B Douglas
Apr 1, 1966·British Journal of Industrial Medicine·K Cramér, L Dahlberg
Jul 1, 1966·Archives of Internal Medicine·J M MorganR E Miller
Jul 7, 1983·The New England Journal of Medicine·V BatumanR P Wedeen
Sep 1, 1983·Arthritis and Rheumatism·P P ReynoldsE W Holmes
Oct 6, 1984·British Medical Journal·S J PocockT P Whitehead
Feb 26, 1981·The New England Journal of Medicine·V BatumanR P Wedeen
Jan 1, 1981·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·J P HansenP E Paulev
May 1, 1982·British Journal of Industrial Medicine·S Araki, K Ushio
Jan 1, 1982·Clinical Science·J K Cruickshank, D G Beevers
May 27, 1982·The New England Journal of Medicine·S G RostandB A Pate
Jan 1, 1982·American Journal of Industrial Medicine·R LilisI J Selikoff
Oct 1, 1981·Toxicology Letters·B C CampbellP A Meredith
Jan 1, 1980·American Journal of Industrial Medicine·R LilisI J Selikoff
Mar 22, 1958·The Medical Journal of Australia·D A HENDERSON
Feb 1, 1961·Canadian Journal of Biochemistry and Physiology·J L BEAREJ A CAMPBELL

❮ Previous
Next ❯

Citations

Nov 1, 1994·American Journal of Industrial Medicine·A C dos SantosN A dos Santos
Oct 1, 1993·Clinical Biochemistry·G Lockitch
Sep 5, 2002·Medical Hypotheses·H C Gonick, J R Behari
May 1, 1993·Archives of Environmental Health·L GerhardssonA C Todd
Nov 6, 2009·Environmental Technology·H W SunZ B Yuan
Mar 1, 1992·British Journal of Industrial Medicine·L GerhardssonO Vesterberg
Jan 1, 2008·Toxicology Mechanisms and Methods·Tian LinJin Tai-Yi
Apr 1, 1993·The American Journal of the Medical Sciences·V Batuman
Mar 8, 2003·Hypertension·Suma VupputuriVecihi Batuman
May 15, 2007·Environmental Toxicology·Tian Lin, Jin Tai-Yi
Jan 1, 1993·British Journal of Industrial Medicine·A CárdenasI Franchini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved